139 related articles for article (PubMed ID: 22196956)
1. Prognostic implications of leg ulcers from hydroxycarbamide therapy in patients with essential thrombocythaemia.
Francis S; Bareford D; Baggott C; Thachil J
Leuk Res; 2012 Apr; 36(4):488-90. PubMed ID: 22196956
[TBL] [Abstract][Full Text] [Related]
2. Anagrelide: new drug. Essential thrombocythaemia: further evaluation needed for this last-resort treatment.
Prescrire Int; 2006 Jun; 15(83):83-6. PubMed ID: 16764090
[TBL] [Abstract][Full Text] [Related]
3. Clinical evaluation of the European LeukaemiaNet criteria for clinicohaematological response and resistance/intolerance to hydroxycarbamide in essential thrombocythaemia.
Hernández-Boluda JC; Alvarez-Larrán A; Gómez M; Angona A; Amat P; Bellosillo B; Martínez-Avilés L; Navarro B; Teruel A; Martínez-Ruiz F; Besses C
Br J Haematol; 2011 Jan; 152(1):81-8. PubMed ID: 21083657
[TBL] [Abstract][Full Text] [Related]
4. Leukemogenic risk of hydroxyurea therapy in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis.
Nand S; Stock W; Godwin J; Fisher SG
Am J Hematol; 1996 May; 52(1):42-6. PubMed ID: 8638610
[TBL] [Abstract][Full Text] [Related]
5. [Hydroxyurea-induced leg ulcers in patients with chronic myeloproliferative disorders].
Olesen LH; Pedersen BB
Ugeskr Laeger; 2001 Dec; 163(49):6908-11. PubMed ID: 11766504
[TBL] [Abstract][Full Text] [Related]
6. Hydroxyurea-induced leg ulcers: is macroerythrocytosis a pathogenic factor?
Vélez A; García-Aranda JM; Moreno JC
J Eur Acad Dermatol Venereol; 1999 May; 12(3):243-4. PubMed ID: 10461646
[TBL] [Abstract][Full Text] [Related]
7. [A lower-leg ulcer during hydroxyurea therapy for essential thrombocythemia].
Iwama H; Kawakubo K; Nehashi Y; Kuriyama Y; Iwase O; Ohyashiki K; Watanabe K; Ebihara Y; Toyama K
Gan To Kagaku Ryoho; 1996 Jun; 23(7):937-9. PubMed ID: 8678547
[TBL] [Abstract][Full Text] [Related]
8. [Hyperalgesic malleolar ulcer: recovery on the withdrawal of hydroxyurea].
Liebschutz S; Quéré I; Lukasik E; Dereure O; Rondes J; Janbon C
Rev Med Interne; 1998 May; 19(5):360-1. PubMed ID: 9775174
[No Abstract] [Full Text] [Related]
9. Prognostic utility of spontaneous erythroid colony formation and JAK2 mutational analysis for thrombotic events in essential thrombocythaemia.
Weston H; Cowell V; Grimmett K; Saal R; Jones M; Mills T; Gill D; Marlton P; Bird R; Mollee P
Intern Med J; 2011 May; 41(5):408-15. PubMed ID: 20681956
[TBL] [Abstract][Full Text] [Related]
10. Implications of the consensus definition of clinical resistance and intolerance to hydroxyurea for clinical practice.
Reilly JT
Eur J Haematol Suppl; 2007 Oct; (68):32-4. PubMed ID: 17727564
[No Abstract] [Full Text] [Related]
11. Combination therapy of hydroxycarbamide with anagrelide in patients with essential thrombocythemia in the evaluation of Xagrid(R) efficacy and long-term safety study.
Gugliotta L; Besses C; Griesshammer M; Harrison C; Kiladjian JJ; Coll R; Smith J; Abhyankar B; Birgegård G
Haematologica; 2014 Apr; 99(4):679-87. PubMed ID: 24334294
[TBL] [Abstract][Full Text] [Related]
12. [Ulcers on the legs and feet: a seldom recognised side effect of hydroxyurea].
Janssen JJ; Ossenkoppele GJ
Ned Tijdschr Geneeskd; 2003 Aug; 147(31):1517-20. PubMed ID: 12924084
[TBL] [Abstract][Full Text] [Related]
13. [Leg ulcers in patient affected by polycythemia vera in treatment with hydroxycarbamide. Case report].
Chiummariello S; Arleo S; Alfano C
G Chir; 2010 Mar; 31(3):120-3. PubMed ID: 20426925
[TBL] [Abstract][Full Text] [Related]
14. A case of hydroxyurea-induced leg ulcer after definitive treatment suspension in a patient affected by thrombocythemia: effectiveness of a new collagenase.
Fioramonti P; Fino P; Parisi P; Scuderi N; Onesti MG
In Vivo; 2012; 26(6):1053-6. PubMed ID: 23160693
[TBL] [Abstract][Full Text] [Related]
15. Leg ulcer in a patient associated with hydroxyurea therapy.
Dissemond J; Hoeft D; Knab J; Franckson T; Kroger K; Goos M
Int J Dermatol; 2006 Feb; 45(2):158-60. PubMed ID: 16445510
[TBL] [Abstract][Full Text] [Related]
16. [Anagrelide in primary thrombocythemia].
Knutsen H; Hysing J
Tidsskr Nor Laegeforen; 2001 May; 121(12):1478-82. PubMed ID: 11449771
[TBL] [Abstract][Full Text] [Related]
17. Leg ulcers in elderly on hydroxyurea: a single center experience in Ph- myeloproliferative disorders and review of literature.
Ruzzon E; Randi ML; Tezza F; Luzzatto G; Scandellari R; Fabris F
Aging Clin Exp Res; 2006 Jun; 18(3):187-90. PubMed ID: 16804363
[TBL] [Abstract][Full Text] [Related]
18. [Diagnosis and treatment of essential thrombocythemia].
Kuramoto A
Rinsho Ketsueki; 1995 May; 36(5):480-6. PubMed ID: 7783354
[TBL] [Abstract][Full Text] [Related]
19. Practical approach to treating essential thrombocythaemia: case studies.
Reilly JT
Eur J Haematol Suppl; 2007 Oct; (68):40-2. PubMed ID: 17727566
[No Abstract] [Full Text] [Related]
20. Long-term follow-up of 386 consecutive patients with essential thrombocythemia: safety of cytoreductive therapy.
Palandri F; Catani L; Testoni N; Ottaviani E; Polverelli N; Fiacchini M; De Vivo A; Salmi F; Lucchesi A; Baccarani M; Vianelli N
Am J Hematol; 2009 Apr; 84(4):215-20. PubMed ID: 19208420
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
